早期糖尿病肾脏微血管病变对糖化血红蛋白及尿微量白蛋白水平的影响  

Effect of early diabetic renal microangiopathy with glycated hemoglobin(HbAlc) and urinary microproteins

作　　者：刘文晖 

机构地区：[1]山西省垣曲县中条山集团总医院,043700

出　　处：《临床合理用药杂志》2011年第6期9-10,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的探讨早期糖尿病肾脏微血管病变与糖化血红蛋白(HbA1c)、尿微量白蛋白(mALB)水平的相关性。方法选择糖尿病肾脏微血管病变患者75例为观察组,无眼底病变的糖尿病患者70例为对照组,比较2组空腹血糖、HbA1c、mALB检测结果。结果观察组空腹血糖、HbA1c、mALB均高于对照组,差异有统计学意义(P<0.01)。结论糖尿病患者监测血糖的同时还应监测HbA1c、mALB,其对于预防早期糖尿病微血管病变,特别是肾脏早期微血管病变具有重要意义。Objective To explore the correlation between early diabetic renal microangiopathy and glycated hemoglobin（HbA1c）,as well as urinary microproteins（mALB）.Methods 75 cases with diabetic renal microangiopathy were chosen as the observation group,and 70 diabetes patients without diabetic retinopathy were chosen as the control group.The FPG,HbA1c,mALB of 2 groups were compared.Results The FPG,HbA1c,mALB of the observation group were respectively higher than those of the control group,and the differences were statistically significant（P 0.01）.Conclusion The diabetes patients should monitor blood sugar,and at the same time,the FPG,HbA1c and mALB should be monitored,which is of great significance for preventing early diabetic microangiopathy,especially early renal microangiopathy.

关 键 词：糖尿病肾病 微血管病变 糖化血红蛋白 尿微量白蛋白 

分 类 号：R587.1[医药卫生—内分泌]